Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03087344 · ClinicalTrials.gov registry record · NA
Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis
A NA study, sponsored by VA Connecticut Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03087344: Completed NA study, sponsored by VA Connecticut Healthcare System.
NCT03087344 is a NA study that has completed, run by VA Connecticut Healthcare System. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03087344, a NA study, has completed, sponsored by VA Connecticut Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This is a study that will evaluate the utility of measuring liver and spleen stiffness before and after a meal by a non invasive ultrasound based technologies called Fibroscan (Transient elastography) and acoustic radio-frequency impulse (ARFI) in diagnosing or excluding cirrhosis in patients with chronic liver disease who will be getting a liver biopsy.
Primary Outcome
Liver stiffness will be obtained by fibroscan in kPa, Liver stiffness will be obtained pre and post meal, the delta change of liver stiffness will be computed in an AUROC to see the Sensitivity, specificity, positive predictive value and negative predictive value of the delta change and diagnosing or excluding cirrhosis
Interventions
- DEVICE Fibroscan
- DEVICE Fibroscan and Acoustic Radiation Force Impulse
- DEVICE Acoustic Radiation Force Impulse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-10-31 |
| Est. Completion | 2018-06-30 |
| Phase | NA |
What the finished NCT03087344 record still lists
NCT03087344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Fibroscan is the first listed.
NCT03087344 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03087344 about?
NCT03087344 is a clinical study titled "Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis". This is a study that will evaluate the utility of measuring liver and spleen stiffness before and after a meal by a non invasive ultrasound based technologies called Fibroscan (Transient elastography) and acoustic radio-frequency impulse (ARFI) in diagnosing or excluding cirrhosis in patients with c...
What is the current status of trial NCT03087344?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-10-31. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03087344?
The interventions under investigation include: Fibroscan (DEVICE), Fibroscan and Acoustic Radiation Force Impulse (DEVICE), Acoustic Radiation Force Impulse (DEVICE).
Who is sponsoring clinical trial NCT03087344?
This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03087344's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI